Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crosspoint Capital is a leading private equity investment firm with a singular focus on cybersecurity, privacy, and infrastructure software, investing in and partnering with technology companies globally. It is not active in the life sciences/biotech/pharma/healthcare sector—it does not develop drugs, therapies, or clinical programs, nor does it have a research platform or pipeline in these areas. Its value creation model centers on leveraging deep operational and technical expertise to support the growth and transformation of cybersecurity and software infrastructure businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crosspoint Capital.